OUTLOOK THERAPEUTICS, INC. Shareholders' Equity
OUTLOOK THERAPEUTICS, INC. (OTLK) had Shareholders' Equity of -$10.39 million as of 2026-06-30, per its 10-Q filed 2026-08-18.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:StockholdersEquity · last filed 2026-08-18
- 2026-06-30: Stockholders' Equity Attributable to Parent -$10.39M.
- 2026-03-31: Stockholders' Equity Attributable to Parent -$28.99M.
- 2025-12-31: Stockholders' Equity Attributable to Parent -$38.55M.
- 2025-09-30: Stockholders' Equity Attributable to Parent -$32.19M.
| Period end | Stockholders' Equity Attributable to Parent | Stockholders' Equity Attributable to Parent as first filed |
|---|---|---|
| 2026-06-30 | -$10.39M 10-Q · filed 2026-08-18 | |
| 2026-03-31 | -$28.99M 10-Q · filed 2026-08-18 | |
| 2025-12-31 | -$38.55M 10-Q · filed 2026-08-18 | |
| 2025-09-30 | -$32.19M 10-Q · filed 2026-08-18 | |
| 2025-06-30 | -$37.19M 10-Q · filed 2026-08-18 | |
| 2025-03-31 | -$32.46M 10-Q · filed 2026-08-18 | |
| 2024-12-31 | -$50.29M 10-Q · filed 2026-08-18 | |
| 2024-09-30 | -$73.08M 10-Q · filed 2026-08-18 | |
| 2024-06-30 | -$83.67M 10-Q · filed 2025-08-14 | |
| 2024-03-31 | -$134.24M 10-Q · filed 2025-08-14 | |
| 2023-12-31 | -$24.34M 10-Q · filed 2025-08-14 | |
| 2023-09-30 | -$14.44M 10-K · filed 2025-12-19 | |
| 2023-06-30 | -$5.50M 10-Q · filed 2024-08-14 | |
| 2023-03-31 | $10.49M 10-Q · filed 2024-08-14 | |
| 2022-12-31 | $15.76M 10-Q · filed 2024-08-14 | |
| 2022-09-30 | $8.74M 10-K · filed 2024-12-27 | |
| 2022-06-30 | $20.08M 10-Q · filed 2023-08-14 | |
| 2022-03-31 | $35.96M 10-Q · filed 2023-08-14 | |
| 2021-12-31 | $48.82M 10-Q · filed 2023-08-14 | |
| 2021-09-30 | $4.61M 10-K · filed 2023-12-22 | |
| 2021-06-30 | $12.75M 10-Q · filed 2022-08-10 | |
| 2021-03-31 | $20.65M 10-Q · filed 2022-08-10 | |
| 2020-12-31 | -$10.47M 10-Q · filed 2022-08-10 | |
| 2020-09-30 | $2.83M 10-K · filed 2022-12-29 | |
| 2020-06-30 | $10.97M 10-Q · filed 2021-08-13 | |
| 2020-03-31 | -$20.52M 10-Q · filed 2021-08-13 | |
| 2019-12-31 | -$30.93M 10-Q · filed 2021-05-14 | |
| 2019-09-30 | -$16.13M 10-K · filed 2021-12-23 | |
| 2019-06-30 | -$6.56M 10-Q · filed 2019-08-14 | |
| 2019-03-31 | -$28.09M 10-Q · filed 2019-05-15 | |
| 2018-12-31 | -$26.35M 10-Q · filed 2019-02-14 | |
| 2018-09-30 | -$25.54M 10-K · filed 2020-12-23 | |
| 2018-06-30 | -$13.20M 10-Q · filed 2018-08-14 | |
| 2018-03-31 | -$33.57M 10-Q · filed 2018-05-15 | |
| 2017-12-31 | -$25.09M 10-Q · filed 2018-02-14 | |
| 2017-09-30 | -$33.65M 10-K · filed 2018-12-18 | |
| 2017-06-30 | -$28.94M 10-Q · filed 2017-08-14 | |
| 2017-03-31 | -$26.85M 10-Q · filed 2017-05-15 | |
| 2016-12-31 | -$21.83M 10-Q · filed 2017-02-14 | |
| 2016-09-30 | -$5.17M 10-K · filed 2017-12-29 | -$5.20M 10-K · filed 2016-12-29 |
| 2016-06-30 | $1.56M 10-Q · filed 2016-08-15 | |
| 2016-03-31 | -$37.86M 10-Q · filed 2016-06-27 | |
| 2015-09-30 | -$54.22M 10-K · filed 2016-12-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Acumen Pharmaceuticals, Inc. (ABOS) | United States | $0.162B | -1.83 |
| Humacyte, Inc. (HUMA) | United States | $0.155B | -2.26 |
| Voyager Therapeutics, Inc. (VYGR) | United States | $0.173B | -1.99 |
| PRECISION BIOSCIENCES INC (DTIL) | United States | $0.175B | -3.95 |
| Coherus Oncology, Inc. (CHRS) | United States | $0.182B | -1.63 |
| Tenaya Therapeutics, Inc. (TNYA) | United States | $0.140B | -1.60 |
| Alpha Cognition Inc. (ACOG) | $0.185B | -6.77 | |
| Caribou Biosciences, Inc. (CRBU) | United States | $0.134B | -1.79 |
| Armata Pharmaceuticals, Inc. (ARMP) | United States | $0.132B | |
| Neumora Therapeutics, Inc. (NMRA) | United States | $0.132B | -1.48 |